查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞健康篩查市場 - 全球行業規模、份額、趨勢、機遇和預測，2018-2028 年：按測試類型、樣本、採集點和地區細分
市場調查報告書
商品編碼
1255233

細胞健康篩查市場 - 全球行業規模、份額、趨勢、機遇和預測，2018-2028 年：按測試類型、樣本、採集點和地區細分

Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Test Type, By Sample, By Site of Collection, By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在預測期內，全球細胞健康篩查市場預計將出現驚人的增長。

這很可能是由於久坐不動的生活方式的興起和人口老齡化，導致糖尿病和肥胖等疾病的出現。 此外，為保持健康生活而採用端粒性能計劃（例如健康飲食和鍛煉）的人數正在增加，健康預期壽命的重要性日益增加，並且採用直接面向客戶的方法也越來越多。因此，預計在預測期內會有顯著增長。 此外，全球範圍內易患各種疾病和肥胖的老年人口不斷增加，進一步增加了對細胞健康篩查的需求，預計這將推動市場增長至 2028 年。 此外，由於飲食不當以及各種慢性疾病，全球越來越多的癌症患者也在預測期內增加了對細胞健康檢查的需求。 據估計，今年美國將有 66,470 人（48,520 名男性和 17,950 名女性）被診斷出患有頭頸癌。 同樣，越來越多的用於製造新藥和補充劑的各種臨床前研究的研發項目也在預測期內增加了對細胞健康篩查市場的需求。

慢性病患病率的增加推動了市場增長。

在預測期內，越來越多地採用端粒性能計劃預計將為全球細胞健康篩查市場帶來利潤豐厚的增長。 慢性病患病率的增加增加了對健康生活方式的需求，預計這將推動市場增長多年。 2001 年全球約 46% 的疾病和 5650 萬人死亡中的 60% 是由慢性病引起的。 多種因素參與細胞衰老的變化，包括體力活動、睡眠和心理障礙。 過度的吸煙和飲酒習慣也會導致各種慢性疾病，使細胞健康檢查變得更加苛刻。 端粒檢測的使用為臨床醫生提供了對代謝和遺傳疾病的洞察力，為患者提供早期診斷和及時的個性化治療計劃。 然而，對細胞篩選的認識和研究不斷增加導致對試劑盒檢測的需求不斷增加，預計這將在預測期內進一步推動市場增長。 根據美國國家癌症研究所的數據，2018 年美國診斷出 1,735,350 例新的癌症病例。

不斷增長的老年人口推動市場增長

由於人口增長、過度飲酒、吸煙、缺乏鍛煉、高體重指數以及水果和蔬菜攝入量低，預計糖尿病和肥胖症等生活方式相關疾病的患病率會增加. 預計在此期間市場將進一步增長。 預計老年人口的增加以及隨之而來的對細胞健康篩查的需求將推動市場增長。 2020 年，估計美國將診斷出 1,806,590 名新癌症患者，606,520 人將死於該病。

近期發展

  • 例如，LabCorp 於 2022 年 4 月宣布，它已針對其提供的各種診斷和篩查測試推出了上門收集服務。
  • 例如，2020 年 9 月，Genova Diagnostics 與 LifeLabs 的子公司 Rocky Mountain Analytical 合作。 該合作夥伴關係將使加拿大患者和診所更容易獲得 Genova 的測試。

可自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第 5 章全球細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型（單測試面板/多測試面板）
    • 通過樣本（血液、唾液、尿液等）
    • 按收集點（家庭、醫院/診所、診斷機構等）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按測試類型
    • 按樣本
    • 按收集站點
    • 按地區

第六章北美細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型
    • 按樣本
    • 按收集點
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章歐洲細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型
    • 按樣本
    • 按收集站點
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太地區細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型
    • 按樣本
    • 按收集點
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章南美細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型
    • 按樣本
    • 按收集點
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲細胞健康篩查市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按測試類型
    • 按樣本
    • 按收集點
    • 按國家
  • MEA：國家分析
    • 南非細胞健康檢查
    • 沙特阿拉伯細胞健康檢查
    • 阿聯酋細胞健康檢查

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第13章競爭格局

  • 業務概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT 分析
    • Telomere Diagnostics, Inc.
    • Quest Diagnostics, Inc.
    • Laboratory Corporation of America Holdings
    • SpectraCell Laboratories, Inc.
    • Cell Science Systems Corporation
    • Immundiagnostik AG
    • Repeat Diagnostics, Inc.
    • OPKO Health, Inc.
    • Genova Diagnostics, Inc.
    • Titanovo, Inc.

第 14 章戰略建議

簡介目錄
Product Code: 14418

The Global Cellular Health Screening Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing sedentary lifestyle and an aging population, consequently resulting in diseases like diabetes and obesity. Additionally, the growing adoption of telomere performance programs for maintaining a healthy life, such as maintaining a healthy weight with healthy eating, exercise regularly along with the growing importance of healthy life expectancy and the growing adoption of direct to customer approach, is expected to create significant growth during the forecasted period. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cellular health screening, thereby fuelling market growth through 2028. Besides, the growing number of cancer patients due to bad food habits across the globe, along with different chronic diseases, is increasing the demand for cellular health screening during the forecast period. This year, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States. Similarly, an increase in research and development projects for different pre-clinical studies can make new drugs or supplements enhance the demand for the cellular health screening market in the forecast period.

The growing Prevalence of Chronic Diseases is Driving the Market's Growth.

Increasing adoption of telomere performance programs is expected to create lucrative growth for the global cellular health screening market during the forecast period. Due to the increasing prevalence of chronic diseases, the demand for leading a healthy lifestyle has increased, which is further expected to drive market growth over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions. Different factors are responsible for changes in cellular aging, such as physical activity, sleep, and psychological disorders. Also, excessive smoking and drinking habits can create different types of chronic diseases, which will further demand cellular health screening. The usage of telomere tests provides clinicians with insights into metabolic and genetic diseases with early diagnosis and timely personalized treatment plans for patients. However, growing awareness and research about cellular screening have led to a rise in the demand for kit tests, which is further expected to boost the market growth during the forecast period. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States.

Increasing Geriatric Population Propelling the Market Growth

The increasing prevalence rate of lifestyle disorders such as diabetes and obesity, excessive alcohol consumption, tobacco use, low physical activity, high body mass index, and low intake of fruits and vegetables because of a growing population is further expected to create a lucrative growth of the market during the forecast period. The growing geriatric population and its consequent growth are expected to raise the demand for cellular health screening, in turn propelling the growth of the market. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States, and 606,520 people died from the disease.

Market Segmentation

The global cellular health screening market can be segmented by test type, sample, site of collection, and by region. Based on test type, the market can be divided into Single Test Panels v/s Multi Test Panels. Based on the sample, the market can be segmented into Blood, Saliva, Urine, and Others. Based on the site of collection, the market can be differentiated into homes, Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global cellular health screening market on account of the growing demand for maintaining healthy life expectancy, along with the growing adoption of new technology in the country.

Market Players

Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. are some of the leading players operating in the Global Cellular Health Screening Market.

Recent Developments

  • For instance, Lab Corp announced in April 2022 that it has launched a home collection service for various diagnostic and screening test offerings of the company.
  • For example, in September 2020, Genova Diagnostics partnered with Rocky Mountain Analytical, a subsidiary of LifeLabs. The partnership allowed greater accessibility of Genova's tests for Canadian patients and clinics.

Report Scope

In this report, global cellular health screening systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cellular Health Screening Market, By Test Type:

  • Single Test Panels
  • Multi-Test Panels

Cellular Health Screening Market, By Sample:

  • Blood
  • Saliva
  • Urine
  • Others

Cellular Health Screening Market, By Site of Collection:

  • Home
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Cellular Health Screening Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cellular Health Screening Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cellular Health Screening Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Single Test Panels v/s Multi Test Panels)
    • 5.2.2. By Sample (Blood, Saliva, Urine, Others)
    • 5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Site of Collection
    • 5.3.4. By Region

6. North America Cellular Health Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Site of Collection
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cellular Health Screening Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Site of Collection
    • 6.3.2. Canada Cellular Health Screening Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Site of Collection
    • 6.3.3. Mexico Cellular Health Screening Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Site of Collection

7. Europe Cellular Health Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Site of Collection
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cellular Health Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Site of Collection
    • 7.3.2. Germany Cellular Health Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Site of Collection
    • 7.3.3. United Kingdom Cellular Health Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Site of Collection
    • 7.3.4. Italy Cellular Health Screening Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Site of Collection
    • 7.3.5. Spain Cellular Health Screening Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Site of Collection

8. Asia-Pacific Cellular Health Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Site of Collection
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cellular Health Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Site of Collection
    • 8.3.2. India Cellular Health Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Site of Collection
    • 8.3.3. Japan Cellular Health Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Site of Collection
    • 8.3.4. South Korea Cellular Health Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Site of Collection
    • 8.3.5. Australia Cellular Health Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Site of Collection

9. South America Cellular Health Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Site of Collection
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cellular Health Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Site of Collection
    • 9.3.2. Argentina Cellular Health Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Site of Collection
    • 9.3.3. Colombia Cellular Health Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Site of Collection

10. Middle East and Africa Cellular Health Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Site of Collection
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cellular Health Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Site of Collection
    • 10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Site of Collection
    • 10.3.3. UAE Cellular Health Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Site of Collection

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Telomere Diagnostics, Inc.
    • 13.6.2. Quest Diagnostics, Inc.
    • 13.6.3. Laboratory Corporation of America Holdings
    • 13.6.4. SpectraCell Laboratories, Inc.
    • 13.6.5. Cell Science Systems Corporation
    • 13.6.6. Immundiagnostik AG
    • 13.6.7. Repeat Diagnostics, Inc.
    • 13.6.8. OPKO Health, Inc.
    • 13.6.9. Genova Diagnostics, Inc.
    • 13.6.10. Titanovo, Inc.

14. Strategic Recommendations